GSK to Sell Two Travel Vaccines to Danish Biotech Firm
GSK to Sell Two Travel Vaccines to Danish Biotech Firm
GlaxoSmithKline Plc said on Monday it will sell two travel vaccines to Denmark-based biotechnology company Bavarian Nordic for an upfront payment of 301 million euros ($335.71 million).